Shopping cart
Your cart empty!
Terms of use dolor sit amet consectetur, adipisicing elit. Recusandae provident ullam aperiam quo ad non corrupti sit vel quam repellat ipsa quod sed, repellendus adipisci, ducimus ea modi odio assumenda.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Do you agree to our terms? Sign up
India has recorded a significant increase in measles cases during the first half of 2026, reporting 26,627 infections, making it the country with the second-highest number of reported measles cases globally, according to data from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC).
The latest figures have raised fresh questions about India's surveillance system, transparency in reporting and the progress of its ambitious goal to eliminate measles and rubella by 2026.
According to international surveillance data, India has already exceeded the 18,794 measles cases reported during the whole of 2025.
Only Bangladesh, which is battling a major measles outbreak, has reported more infections this year with 42,127 cases and nearly 800 deaths.
Despite the increase, there have been no reports of widespread nationwide outbreaks or detailed official information identifying the states and districts most affected.
India has repeatedly postponed its measles and rubella elimination target after missing earlier deadlines in 2015, 2020, and 2023.
The latest rise in infections comes as the country aims to eliminate the disease by 2026, making effective surveillance, vaccination and rapid outbreak response even more critical.
Public health experts have also highlighted the lack of publicly available district-wise data on infections and deaths, making it difficult to assess the true extent of the outbreak.
WHO surveillance data shows fluctuations in reported measles cases over the past few years:
The major nationwide outbreak in 2022 was largely attributed to disruptions in routine childhood immunisation during the COVID-19 pandemic.
Measles is a highly contagious viral disease that spreads through respiratory droplets when an infected person coughs or sneezes.
Common symptoms include:
Although there is no specific antiviral treatment, supportive care—including fever management and Vitamin A supplementation—can help reduce complications.
Children may develop severe illnesses such as pneumonia and encephalitis (brain inflammation), which can be life-threatening.
Experts also note that measles can weaken the immune system for months after recovery, increasing vulnerability to other infections.
Virologist Dr T Jacob John, former professor at Christian Medical College (CMC), Vellore and former co-chair of India's Measles-Rubella Task Force, said the overall case numbers alone should not trigger panic.
However, he expressed concern about the country's elimination efforts and the limited public availability of surveillance data.
According to Dr John, India currently lacks publicly accessible district- and state-level information on measles cases, making it difficult to monitor outbreak patterns or assess the effectiveness of control measures.
Despite the rise in infections, vaccination coverage has shown steady improvement.
According to the latest WHO-UNICEF Estimates of National Immunisation Coverage (WUENIC):
Health experts believe maintaining high vaccination coverage while rapidly detecting and controlling local outbreaks will be essential if India is to achieve its long-delayed measles elimination target.
India has reported 26,627 measles cases during the first half of 2026, according to WHO and CDC data.
Bangladesh has reported the highest number of measles cases in 2026, with over 42,000 infections.
India aims to eliminate measles and rubella by 2026, after previously missing elimination targets in 2015, 2020 and 2023.
Measles is prevented through vaccination. Under India's Universal Immunisation Programme, children receive two doses of the Measles-Rubella (MR) vaccine.
Experts say improved vaccination rates are encouraging, but greater surveillance transparency and quicker identification of local outbreaks are essential to eliminate measles.
4
Published: 1h ago